Table 1.
Location | Incidence rate (cases per 100,000 per year) | ||
---|---|---|---|
Females | Males | Total | |
STS of head and neck | 0.16 | 0.35 | 0.24 |
STS of limbs | 0.75 | 1.09 | 0.90 |
STS of superficial trunk | 0.33 | 0.53 | 0.42 |
STS of mediastinum | 0.01 | 0.01 | 0.01 |
STS of heart | 0.02 | 0.02 | 0.02 |
STS of breast | 0.38 | 0.00 | 0.19 |
STS of uterus | 1.44 | – | – |
STS of paratestis | – | 0.03 | – |
STSs of other genitourinarya | 0.46 | 0.13 | 0.30 |
STS of viscera | 0.23 | 0.31 | 0.27 |
STS of retroperitoneum and peritoneum | 0.13 | 0.18 | 0.15 |
STS of pelvis | 0.20 | 0.24 | 0.22 |
STS of skin | 0.31 | 0.55 | 0.42 |
STS of paraorbit | 0.01 | 0.01 | 0.01 |
STS of brain and other nervous system | 0.15 | 0.16 | 0.15 |
Embryonal rhabdomyosarcoma of soft tissue | 0.08 | 0.11 | 0.10 |
Alveolar rhabdomyosarcoma of soft tissue | 0.04 | 0.06 | 0.05 |
Ewing's sarcoma of soft tissue | 0.02 | 0.05 | 0.03 |
STS other and unspecified | 0.20 | 0.27 | 0.23 |
Total STSsb | 4.92 | 4.10 | 4.48 |
STS, soft‐tissue sarcoma; ASR, age standardized rates; GIST, gastrointestinal stromal tumors. Figures in bold indicate sites with highest ASR.
Vulva, vagina, ovary, penis, prostate, testis, kidney, renal pelvis, ureter, bladder, and urethra.
Excludes GIST and Kaposi sarcoma.